Prevalence, risk factors, and management practices of primary dysmenorrhea among young females

dc.contributor.authorKarout, Samar
dc.contributor.authorSoubra, Lama
dc.contributor.authorRahme, Deema W.
dc.contributor.authorKarout, Lina
dc.contributor.authorKhojah, Hani M.J.
dc.contributor.authorItani, Rania Mazen
dc.contributor.departmentDiagnostic Radiology
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:41:12Z
dc.date.available2025-01-24T11:41:12Z
dc.date.issued2021
dc.description.abstractBackground: Primary dysmenorrhea (PD) is one of the most common gynecological conditions among young females, which has a significant negative impact on health-related quality of life and productivity. Despite its high prevalence, the evidence is limited regarding the management-seeking practices and its perceived effectiveness among females with PD. Methods: This is a cross-sectional study conducted among 550 female students in six universities across Lebanon. The prevalence of PD, associated risk factors, and management-seeking practices were assessed using a self-administered questionnaire. Results: The prevalence of PD was 80.9%. Most of the females with PD described their menstrual pain as moderate (56%) to severe (34.6%), which significantly affected their daily activities and studying ability (P < 0.001). The major risk factors associated with PD included heavy menstrual flow (adjusted odds ratio [AOR] = 10.28), family history of PD (AOR = 2.52), history of weight loss attempt (AOR = 2.05), and medical specialization (AOR = 1.663). Only 36.9% of females with PD sought formal medical advice. Most dysmenorrheic females (76.4%) received medications for the management of PD, and remarkably none of them took hormonal contraceptives. Drugs commonly used for PD were mefenamic acid (26.2%), ibuprofen (25%), and paracetamol (11.5%), which were administered when the pain started (58.2%). All medications were significantly effective in reducing the pain score (P = 0.001), and most NSAIDs were more potent than paracetamol in managing PD (P = 0.001). However, no significant difference in adverse effects among medications was revealed. Moreover, no superiority of any individual NSAID for pain relief was established. Nevertheless, mefenamic acid was associated with the lowest risk of abdominal pain (OR: 0.03, P = 0.005) and the highest risk of flank pain (OR = 12, P = 0.02). Conclusions: Suboptimal management of PD is practiced among university students in Lebanon. Therefore, health care providers should educate dysmenorrheic females to optimize the self-management support of PD. Furthermore, future research is required to investigate females’ misconceptions about hormonal contraceptives in the management of PD, aiming to raise awareness and correct misconceptions. © 2021, The Author(s).
dc.identifier.doihttps://doi.org/10.1186/s12905-021-01532-w
dc.identifier.eid2-s2.0-85118698681
dc.identifier.pmid34749716
dc.identifier.urihttp://hdl.handle.net/10938/29699
dc.language.isoen
dc.publisherBioMed Central Ltd
dc.relation.ispartofBMC Women's Health
dc.sourceScopus
dc.subjectLebanon
dc.subjectManagement-seeking practices
dc.subjectMenstrual pain
dc.subjectNon-steroidal anti-inflammatory drugs
dc.subjectPrevalence
dc.subjectPrimary dysmenorrhea
dc.subjectRisk factors
dc.subjectCross-sectional studies
dc.subjectDysmenorrhea
dc.subjectFemale
dc.subjectHumans
dc.subjectQuality of life
dc.subjectIbuprofen
dc.subjectMefenamic acid
dc.subjectParacetamol
dc.subjectAbdominal pain
dc.subjectAdult
dc.subjectArticle
dc.subjectBody weight loss
dc.subjectClinical practice
dc.subjectCross-sectional study
dc.subjectFamily history
dc.subjectHuman
dc.subjectMajor clinical study
dc.subjectMenstruation
dc.subjectObservational study
dc.subjectRisk factor
dc.subjectUniversity student
dc.titlePrevalence, risk factors, and management practices of primary dysmenorrhea among young females
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2021-5748.pdf
Size:
1.1 MB
Format:
Adobe Portable Document Format